HUNTINGTON BEACH, CALIF. – Soberlink, the leader in mobile breath alcohol detection technology, announced today its inclusion in an expert panel consensus paper about the use of remote monitoring in the clinical treatment of alcohol use disorder.
The consensus paper – written by a panel of nine alcohol use disorder treatment and research experts – was recently published in the Journal of Addiction Medicine. The paper examines the Soberlink System as a method of BAC collection and monitoring in various recovery situations. The experts concluded that remote monitoring could play a vital role in successful recovery as a method of deterrent, and a means of early detection and intervention.
…Monitoring serves the dual purpose of measuring symptom improvement and also providing support for decisions on whether and how to adjust subsequent care to reduce the likelihood of relapse.”
“Soberlink technology puts active and involved recovery into the hands of both the patient and the clinician,” says Brad Keays, CEO of Soberlink Healthcare, LLC, “This consensus paper, written by AUD experts, further proves that the Soberlink System belongs in modern recovery care programs.”
New healthcare legislation and insurance regulations have made AUD treatment a requirement from most health organizations. The publishing of this consensus paper only further demonstrates that the conversation around alcohol use disorder continues to evolve toward personalized and long-term models of care.
Soberlink is committed to changing the perception of alcohol use disorder by developing technology for addiction and recovery management. In 2016, the Soberlink Cellular Device gained FDA 510(k) clearance for medical use.
Since 2011, Soberlink has become the fastest growing recovery system on the market. The Soberlink System promotes accountability and connectivity with real-time BAC testing. Soberlink’s passionate pursuit of better recovery drove the company to develop the world’s first web connected breathalyzer with facial recognition software. The company remains at the forefront of innovation in the handheld, mobile breath category with the patented Soberlink Cellular, Soberlink Bluetooth and Sober Sky Web Portal.
About Journal of Addiction Medicine
The mission of Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine, is to promote excellence in the practice of addiction medicine and in clinical research as well as to support Addiction Medicine as a mainstream medical specialty. Published six times a year, the Journal is designed for all physicians and other mental health professionals who need to keep up-to-date with the treatment of addiction disorders. Under the guidance of an esteemed Editorial Board, peer-reviewed articles published in the Journal focus on developments in addiction medicine as well as on treatment innovations and ethical, economic, forensic, and social topics.
About the American Society of Addiction Medicine – ASAM
The American Society of Addiction Medicine is a national medical specialty society of more that 4,300 physicians and associated health professionals. Its mission is to increase access to and improve the quality of addiction treatment, to educate physicians, and other health care providers and the public, to support research and prevention, to promote the appropriate role of the physician in the care of patients with addictive disorders, and to establish addiction medicine as a specialty recognized by professional organizations, governments, physicians, purchasers and consumers of health care services and the general public. ASAM was founded in 1954, and has had a seat in the American Medical Association House of Delegates since 1988.
About the Author Soberlink supports accountability for sobriety through a comprehensive alcohol monitoring system. Combining a breathalyzer with wireless connectivity, the portable design and technology includes facial recognition, tamper detection and real-time reporting. Soberlink proves sobriety with reliability to foster trust and peace of mind.